co
Corporate
Observer
Homepage
Data
Great Britain
Company
MITORX THERAPEUTICS LIMITED

MITORX THERAPEUTICS LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Previous names
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Persons with signficant control statements
  • Data Source

    • Overview

    Company NameMITORX THERAPEUTICS LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 13237941
    JurisdictionEngland/Wales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of MITORX THERAPEUTICS LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities
    • Other business support service activities n.e.c. (82990) / Administrative and support service activities

    Where is MITORX THERAPEUTICS LIMITED located?

    Registered Office Address
    9400 Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    United Kingdom
    Undeliverable Registered Office AddressNo

    What were the previous names of MITORX THERAPEUTICS LIMITED?

    Previous Company Names
    Company NameFromUntil
    IFFLEY BIOTECH LTDMar 02, 2021Mar 02, 2021

    What are the latest accounts for MITORX THERAPEUTICS LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnMar 31, 2025
    Next Accounts Due OnDec 31, 2025
    Last Accounts
    Last Accounts Made Up ToMar 31, 2024

    What is the status of the latest confirmation statement for MITORX THERAPEUTICS LIMITED?

    Last Confirmation Statement Made Up ToMar 01, 2026
    Next Confirmation Statement DueMar 15, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToMar 01, 2025
    OverdueNo

    What are the latest filings for MITORX THERAPEUTICS LIMITED?

    Filings
    DateDescriptionDocumentType

    Resolutions

    Resolutions
    		1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    		RES10
    capital

    Resolution of removal of pre-emption rights

    		RES11

    Confirmation statement made on Mar 01, 2025 with updates

    		9 pagesCS01

    Statement of capital following an allotment of shares on Dec 16, 2024

    • Capital: GBP 881.9194
    		3 pagesSH01

    Resolutions

    Resolutions
    		1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of allotment of securities

    		RES10

    Resolutions

    Resolutions
    		1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of removal of pre-emption rights

    		RES11
    capital

    Resolution of allotment of securities

    		RES10

    Appointment of Dr David Mark Anthony Holbrook as a director on Aug 02, 2024

    		2 pagesAP01

    Total exemption full accounts made up to Mar 31, 2024

    		10 pagesAA

    Second filing of a statement of capital following an allotment of shares on Jun 26, 2024

    • Capital: GBP 815.3451
    		4 pagesRP04SH01

    Statement of capital following an allotment of shares on Jun 14, 2024

    • Capital: GBP 815.3451
    		4 pagesSH01
    Annotations
    DateAnnotation
    Jul 08, 2024Clarification A second filed sh01 was registered on 08/07/24

    Statement of capital following an allotment of shares on Jun 04, 2024

    • Capital: GBP 774.9868
    		3 pagesSH01

    Resolutions

    Resolutions
    		1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of removal of pre-emption rights

    		RES11
    capital

    Resolution of allotment of securities

    		RES10

    Second filing of a statement of capital following an allotment of shares on Apr 11, 2024

    • Capital: GBP 762.5077
    		4 pagesRP04SH01

    Second filing of a statement of capital following an allotment of shares on Apr 05, 2024

    • Capital: GBP 751.6388
    		4 pagesRP04SH01

    Statement of capital following an allotment of shares on Apr 17, 2024

    • Capital: GBP 772.5715
    		3 pagesSH01

    Statement of capital following an allotment of shares on Apr 11, 2024

    • Capital: GBP 765.7281
    		4 pagesSH01
    Annotations
    DateAnnotation
    May 01, 2024Clarification A second filed SH01 was registered on 01/05/2024.

    Statement of capital following an allotment of shares on Apr 05, 2024

    • Capital: GBP 754.8592
    		4 pagesSH01
    Annotations
    DateAnnotation
    May 01, 2024Clarification A second filed SH01 was registered on 01/05/2024.

    Statement of capital following an allotment of shares on Mar 31, 2024

    • Capital: GBP 739.8444
    		3 pagesSH01

    Confirmation statement made on Mar 01, 2024 with updates

    		7 pagesCS01

    Memorandum and Articles of Association

    		51 pagesMA

    Resolutions

    Resolutions
    		1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of alteration of Articles of Association

    		RES01
    capital

    Resolution of allotment of securities

    		RES10

    Memorandum and Articles of Association

    		51 pagesMA

    Resolutions

    Resolutions
    		2 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of adoption of Articles of Association

    		RES01
    capital

    Resolution of removal of pre-emption rights

    		RES11
    capital

    Resolution of allotment of securities

    		RES10

    Statement of capital following an allotment of shares on Oct 30, 2023

    • Capital: GBP 709.9441
    		3 pagesSH01

    Total exemption full accounts made up to Mar 31, 2023

    		10 pagesAA

    Sub-division of shares on Mar 29, 2023

    		4 pagesSH02
    View All Filings

    Who are the officers of MITORX THERAPEUTICS LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    PENNSEC LIMITED
    Wood Street
    EC2V 7AW London
    125
    England
    		Secretary
    Wood Street
    EC2V 7AW London
    125
    England
    Identification TypeUK Limited Company
    Registration Number01751339
    		50775150007
    EDWARDS, Glyn Owain
    Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    9400
    United Kingdom
    		Director
    Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    9400
    United Kingdom
    		United KingdomBritishBiotechnologist3648630001
    FINK, Alexander Michael, The Honourable
    Elm Grove Road
    W5 3JH Ealing
    3
    London
    United Kingdom
    		Director
    Elm Grove Road
    W5 3JH Ealing
    3
    London
    United Kingdom
    		EnglandBritishMd Of Project Etopia245902050001
    HOLBROOK, David Mark Anthony, Dr
    Princes Gardens
    W5 1SD Ealing, London
    27
    United Kingdom
    		Director
    Princes Gardens
    W5 1SD Ealing, London
    27
    United Kingdom
    		United KingdomBritishCompany Director325798630001
    LAW, Norman Milne, Dr
    Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    9400
    United Kingdom
    		Director
    Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    9400
    United Kingdom
    		EnglandBritishScientist280313300001
    REES, Jonathan David
    Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    9400
    United Kingdom
    		Director
    Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    9400
    United Kingdom
    		EnglandBritishChief Executive Officer101672970004
    WHITEMAN, Matthew Loren
    Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    9400
    United Kingdom
    		Director
    Garsington Road
    Oxford Business Park
    OX4 2HN Oxford
    9400
    United Kingdom
    		United KingdomBritishChief Scientific Officer288479320001
    View Detailed Information on Officers and People with Significant Control

    Who are the persons with significant control of MITORX THERAPEUTICS LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Dr Norman Milne Law
    University Of Exeter
    Rennes Drive
    EX4 4RN Exeter
    The Innovation Centre
    Devon
    United Kingdom
    		Mar 02, 2021
    University Of Exeter
    Rennes Drive
    EX4 4RN Exeter
    The Innovation Centre
    Devon
    United Kingdom
    		Yes
    Nationality: British
    Country of Residence: England
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.
    Mr Jonathan David Rees
    University Of Exeter
    Rennes Drive
    EX4 4RN Exeter
    The Innovation Centre
    Devon
    United Kingdom
    		Mar 02, 2021
    University Of Exeter
    Rennes Drive
    EX4 4RN Exeter
    The Innovation Centre
    Devon
    United Kingdom
    		Yes
    Nationality: British
    Country of Residence: England
    Natures of Control
    • The person holds, directly or indirectly, more than 50% but not more than 75% of the shares in the company.
    • The person holds, directly or indirectly, more than 50% but not more than 75% of the voting rights in the company.
    • The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.
    View Detailed Information on Persons with Significant Control

    What are the latest statements on persons with significant control for MITORX THERAPEUTICS LIMITED?

    Persons with signficant control statements
    Notified OnCeased OnStatement
    Jan 25, 2022The company knows or has reasonable cause to believe that there is no registrable person or registrable relevant legal entity in relation to the company
    View Detailed Information on Persons with Significant Control Statements

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0